ARTICLE SUMMARY:
Israel-based Sanara Ventures, backed by an alliance of unlikely partners, Teva and Philips, is mining the rich field of Israeli medtech start-ups, and hopes to offer a solution to a problem plaguing big companies today – the attrition of early-stage companies due to a lack of early-stage funding.
As venture capital dries up for medical device companies, particularly early-stage capital, large multinational device companies have begun to worry.
